Search
18/01/2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Reyes-Leiva, D, Dols-Icardo, O, Sirisi, S, Cortes-Vicente, E, Turon-Sans, J, De Luna, N, Blesa, R, Belbin, O, Montal, V, Alcolea, D, Fortea, J, Lleo, A, Rojas-Garcia, R, Illan-Gala, I. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology. 2022; 12DOI:10.3389/fneur.2021.750543. PMID:35115992. IF:3.400(Q2/5D).
01/01/2022
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
Padilla, C, Montal, V, Walpert, MJ, Hong, YT, Fryer, TD, Coles, JP, Aigbirhio, FI, Hartley, SL, Cohen, AD, Tudorascu, DL, Christian, BT, Handen, BL, Klunk, WE, Holland, AJ, Zaman, SH. Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022; 14(1)DOI:10.1002/dad2.12288. PMID:35386472. IF:(Q/D).
02/11/2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients
Lennol, MP, Sanchez-Dominguez, I, Cuchillo-Ibanez, I, Camporesi, E, Brinkmalm, G, Alcolea, D, Fortea, J, Lleo, A, Soria, G, Aguado, F, Zetterberg, H, Blennow, K, Saez-Valero, J. Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01108-2. PMID:36324176. IF:9.000(Q1/1D).
01/11/2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Jansen, RE, van der Lee, SJ, Gomez-Fonseca, D, de Rojas, I, Dalmasso, MC, Grenier-Boley, B, Zettergren, A, Mishra, A, Ali, M, Andrade, V, Bellenguez, C, Kleineidam, L, Kucukali, F, Sung, YJ, Tesi, N, Vromen, EM, Wightman, DP, Alcolea, D, Alegret, M, Alvarez, I, Amouyel, P, Athanasiu, L, Bahrami, S, Bailly, H, Belbin, O, Bergh, S, Bertram, L, Biessels, GJ, Blennow, K, Blesa, R, Boada, M, Boland, A, Buerger, K, Carracedo, A, Cervera-Carles, L, Chene, G, Claassen, JAHR, Debette, S, Deleuze, JF, de Deyn, PP, Diehl-Schmid, J, Djurovic, S, Dols-Icardo, O, Dufouil, C, Duron, E, Duzel, E, Fladby, T, Fortea, J, Frolich, L, Garcia-Gonzalez, P, Garcia-Martinez, M, Giegling, I, Goldhardt, O, Gobom, J, Grimmer, T, Haapasalo, A, Hampel, H, Hanon, O, Hausner, L, Heilmann-Heimbach, S, Helisalmi, S, Heneka, MT, Hernandez, I, Herukka, SK, Holstege, H, Jarholm, J, Kern, S, Knapskog, AB, Koivisto, AM, Kornhuber, J, Kuulasmaa, T, Lage, C, Laske, C, Leinonen, V, Lewczuk, P, Lleo, A, de Munain, AL, Lopez-Garcia, S, Maier, W, Marquie, M, Mol, MO, Montrreal, L, Moreno, F, Moreno-Grau, S, Nicolas, G, Nothen, MM, Orellana, A, Palhaugen, L, Papma, JM, Pasquier, F, Perneczky, R, Peters, O, Pijnenburg, YAL, Popp, J, Posthuma, D, Pozueta, A, Priller, J, Puerta, R, Quintela, I, Ramakers, I, Rodriguez-Rodriguez, E, Rujescu, D, Saltvedt, I, Sanchez-Juan, P, Scheltens, P, Scherbaum, N, Schmid, M, Schneider, A, Selbaek, G, Selnes, P, Shadrin, A, Skoog, I, Soininen, H, Tarraga, L, Teipel, S, Tijms, B, Tsolaki, M, Van Broeckhoven, C, Van Dongen, J, van Swieten, JC, Vandenberghe, R, Vidal, JS, Visser, PJ, Vogelgsang, J, Waern, M, Wagner, M, Wiltfang, J, Wittens, MMJ, Zetterberg, H, Zulaica, M, van Duijn, CM, Bjerke, M, Engelborghs, S, Jessen, F, Teunissen, CE, Pastor, P, Hiltunen, M, Ingelsson, M, Andreassen, OA, Clarimon, J, Sleegers, K, Ruiz, A, Ramirez, A, Cruchaga, C, Lambert, JC, van der Flier, W. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers. ACTA NEUROPATHOLOGICA. 2022; 144(5)DOI:10.1007/s00401-022-02454-z. PMID:36066633. IF:12.700(Q1/1D).
01/10/2022
The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary
Hampel, H, Elhage, A, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary. Neurodegenerative Disease Management. 2022; 12(5)DOI:10.2217/nmt-2022-0012. PMID:35866715. IF:(Q/D).
01/10/2022
Myelin loss in C9orf72 hexanucleotide expansion carriers
Sirisi, S, Querol-Vilaseca, M, Dols-Icardo, O, Pegueroles, J, Montal, V, Munoz, L, Torres, S, Ferrer-Raventos, P, Iulita, MF, Sanchez-Aced, E, Blesa, R, Illan-Gala, I, Molina-Porcel, L, Borrego-Ecija, S, Sanchez-Valle, R, Clarimon, J, Belbin, O, Fortea, J, Lleo, A. Myelin loss in C9orf72 hexanucleotide expansion carriers. JOURNAL OF NEUROSCIENCE RESEARCH. 2022; 100(10)DOI:10.1002/jnr.25100. PMID:35766328. IF:4.200(Q2/4D).